ALNY vs COLD · P/E 76, rev $2.25B vs rev $2.67B
Alnylam Pharmaceuticals Inc (ALNY) versus Americold Realty Trust (COLD) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Americold Realty Trust (COLD) is a reit - industrial company listed on US.
Latest reported ALNY revenue for 2024-12-31 was $2.25B. Net income was -$278.2M. Revenue was up 23.0% from 2023-12-31 to 2024-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported COLD revenue for 2024-12-31 was $2.67B. Net income was -$94.7M. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. COLD currently screens at market cap $4.75B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. COLD currently screens at market cap $4.75B.
Not investment advice. Open the ALNY and COLD stock pages for the full models.
Not investment advice.